---
title: "IRLA - Antibodies and Sera (and other matrices)"
ocid: "ocds-h6vhtk-0292a6"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0292a6"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-0292a6.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-0292a6.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "SOUTHERN UNIVERSITIES PURCHASING CONSORTIUM (SUPC)"
published: "2021-07-29"
---

# IRLA - Antibodies and Sera (and other matrices)

Buyer: SOUTHERN UNIVERSITIES PURCHASING CONSORTIUM (SUPC)  
Current stage: Award  
OCID: ocds-h6vhtk-0292a6

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0292a6)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-0292a6.json)

## Summary

The Southern Universities Purchasing Consortium (SUPC) is conducting an active tender for the supply of "IRLA - Antibodies and Sera (and other matrices)." This procurement falls under the goods category, specifically focusing on immune sera and immunoglobulins. Bids are due by 26 March 2021, with the award period commencing the same day. The contract is expected to operate across various locations in the UK and has a total estimated value of £32,100,000, which includes a substantial commitment toward antibodies with an estimated yearly expenditure of around £10 million.

This tender presents significant opportunities for businesses in the life sciences and biotechnology sectors, particularly those supplying antibodies, sera, or related matrices. Suppliers that can effectively respond to the flexible specifications outlined, and those with the capabilities to cater to both human and animal product needs, will find themselves well-positioned. Firms should also be aware that future call-off contracts may be partially funded by external sources, including European Union funding, enhancing the competitive landscape for organisations able to meet strict compliance and promotion terms under the framework agreement.

## Notice

The supply of antibodies and sera (and other human and animal matrices). Only members of www.apuc-scot.ac.uk , www.hepcw.ac.uk , www.lupc.ac.uk , www.neupc.ac.uk,www.nwupc.ac.uk , www.supc.ac.uk will have access to the agreement.

### Lot Information

Antibodies

Precise product specifications and quantities are unknown to SUPC. These will be agreed with customers when they call-off the agreement. Historical information has shown on average a PS10M per year spend with Antibodies suppliers. However, this is only an estimation and the value of purchases made under each Framework will depend on Institutions taking up the Frameworks and on suppliers promoting and adhering to the terms of their contracts Additional information: It is anticipated that some of the future call-off contracts under this framework will be part or fully funded from external streams, including European Union (EU) funding (ERDF/ESF) and potentially other research bodies. All funding accessed under this framework will be considered compliant for the purposes of external funding by the named participants.

Options: SUPC will award this Framework Agreement on the basis of 30 months, with 1 option to extend by up to an additional 6 months.

Sera and other matrices

Precise product specifications and quantities are unknown to SUPC. These will be agreed with customers calling-off the agreement. Expenditure across sera suppliers was estimated at less than 2 500 000 GBP for sera, tissue and other blood products. However, this is only an estimation and the value of purchases made under each Framework will depend on Institutions taking up the Frameworks and on suppliers promoting and adhering to the terms of their contracts. Additional information: It is anticipated that some of the future call-off contracts under this framework will be part or fully funded from external streams, including European Union (EU) funding (ERDF/ESF) and potentially other research bodies. All funding accessed under this framework will be considered compliant for the purposes of external funding by the named participants.

Options: SUPC will award this Framework Agreement on the basis of 30 months, with 1 option to extend by up to an additional 6 months.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/018101-2021 |
| Notice type | Tender Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large, SME |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 29 Jul 2021 |
| Submission deadline | 26 Mar 2021 |
| Future notice date | Not specified |
| Award date | 30 Jun 2021 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £32,100,000 |
| Lots value | £32,100,000 |
| Awards value | Not specified |
| Contracts value | £32,100,000 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | SOUTHERN UNIVERSITIES PURCHASING CONSORTIUM (SUPC) |
| Additional buyers | EUROPEAN UNION |
| Locality | READING |
| Post town | Reading |
| Postcode | RG6 6BU |
| Country | England |
| ITL 1 | TLJ South East (England) |
| ITL 2 | TLJ1 Berkshire, Buckinghamshire and Oxfordshire |
| ITL 3 | TLJ16 Berkshire West |
| Local authority | Wokingham |
| Electoral ward | Hillside |
| Westminster constituency | Earley and Woodley |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 18 |
| Supplier names | 2BSCIENTIFIC; AGILENT TECHNOLOGIES; ANTIBODIES.COM; BIO-TECHNE; BIOLEGEND; BIOSERVUK; CAMBRIDGE BIOSCIENCE; CELL SIGNALING TECHNOLOGY EUROPE; ENZO LIFE SCIENCES (UK; FISHER SCIENTIFIC; GENERON; INSIGHT BIOTECHNOLOGY; MERCK LIFE SCIENCE; MILTENYI BIOTEC; OXFORD BIOSYSTEMS; PROTEINTECH EUROPE; STRATECH SCIENTIFIC; TAKARA BIO EUROPE |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
- 33651000 - General anti-infectives for systemic use and vaccines
- 33651500 - Immune sera and immunoglobulins
- 33651510 - Antisera
- 33651520 - Immunoglobulins

## Release History

- 29 Jul 2021 at 13:53 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/018101-2021
- 12 Feb 2021 at 11:05 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/002879-2021

## Notice URLs

- https://uk.eu-spply.com/login.asp?B=SUPC
- https://uk.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=36620&B=SUPC
- https://uk.eu-supply.com/ctm/Company/CompanyInformation/Index/86623
- https://www.supc.ac.uk

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0292a6. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-0292a6.json.